Wegovy Cost Australia 2026: PBS Subsidy vs. Private Pricing Guide
Understanding the cost of Wegovy and other weight loss medications in Australia is important when treatment may involve significant ongoing out-of-pocket expenses. Wegovy (semaglutide) is TGA-approved for weight management in Australia. However, Wegovy is not currently PBS-subsidised for weight loss. Patients prescribed Wegovy for weight management should therefore expect to obtain it on a private prescription and pay the applicable pharmacy price.
Wegovy Cost Australia 2026: Private Pricing and PBS Status Guide
Understanding the cost of Wegovy and other weight loss medications in Australia is important when treatment may involve significant ongoing out-of-pocket expenses.
Wegovy (semaglutide) is TGA-approved for weight management in Australia. However, Wegovy is not currently PBS-subsidised for weight loss. Patients prescribed Wegovy for weight management should therefore expect to obtain it on a private prescription and pay the applicable pharmacy price.
This guide explains the current 2026 pricing landscape, the difference between TGA approval and PBS subsidy, and how patients can access medically supervised weight management treatment.
Key Takeaways
- Wegovy is TGA-approved in Australia for chronic weight management in eligible patients.
- Wegovy is not currently PBS-subsidised for weight loss.
- Most patients prescribed Wegovy for weight management therefore pay the private pharmacy price.
- Ozempic and Wegovy both contain semaglutide but have different approved indications and should not be considered interchangeable for PBS purposes.
- Medication costs vary between pharmacies and according to the prescribed product and dose.
- A doctor must assess whether prescription weight loss medication is clinically appropriate.
Understanding Weight Loss Medications in Australia
GLP-1 (Glucagon-Like Peptide-1) receptor agonists and related medicines have become important options for managing obesity and metabolic disease.
Several medicines are available in Australia, including:
Wegovy (semaglutide) – TGA-approved for chronic weight management.
Mounjaro (tirzepatide) – TGA-approved for chronic weight management and Type 2 Diabetes Mellitus (T2DM).
Saxenda (liraglutide) – TGA-approved for chronic weight management.
Ozempic (semaglutide) – primarily approved for the management of Type 2 Diabetes Mellitus rather than weight management.
Whether a medication is TGA-approved and whether it is subsidised through the PBS are two separate issues.
Is Wegovy on the PBS in 2026?
No. Wegovy is not currently PBS-subsidised for weight loss in Australia.
Although Wegovy is registered by the Therapeutic Goods Administration (TGA) for chronic weight management, TGA approval does not automatically result in Pharmaceutical Benefits Scheme (PBS) funding.
Proposals concerning government-funded access to obesity medicines have been considered through the Pharmaceutical Benefits Advisory Committee (PBAC) process. Until an applicable PBS listing actually takes effect, patients using Wegovy for weight management should expect to obtain it through a private prescription.
Patients should not assume that meeting a particular BMI or having cardiovascular disease automatically entitles them to subsidised Wegovy.
PBS arrangements can change, so patients should check the current PBS Schedule or discuss the latest eligibility information with their doctor or pharmacist.
Who May Be Eligible for Wegovy Treatment?
For chronic weight management in adults, Wegovy is TGA-approved as an adjunct to a reduced-energy diet and increased physical activity for people with an initial:
- BMI (Body Mass Index) of 30 kg/m² or greater, or
- BMI of 27 kg/m² to less than 30 kg/m² with at least one weight-related comorbidity.
These are TGA-approved treatment criteria and should not be confused with PBS subsidy criteria.
The decision to prescribe remains a clinical decision made by the treating doctor after considering the patient's medical history, current medications, contraindications, risks and treatment goals.
Private Wegovy Costs in Australia
Because Wegovy for weight management is not currently PBS-subsidised, patients generally pay the private pharmacy price.
The price can vary according to:
- Dose and formulation
- Pharmacy pricing
- Available stock
- Manufacturer pricing
- Dispensing and delivery arrangements
Patients should confirm the current price directly with their chosen pharmacy because private medicine prices can change.
Wegovy vs Ozempic: Understanding the Difference
Wegovy and Ozempic both contain semaglutide, but they are registered and prescribed for different clinical purposes.
Wegovy is specifically TGA-approved for chronic weight management in eligible patients.
Ozempic is primarily indicated for Type 2 Diabetes Mellitus and has PBS restrictions applying to eligible patients receiving it for approved subsidised indications.
The fact that Ozempic may be PBS-subsidised for eligible patients with diabetes does not mean Wegovy is PBS-subsidised for weight loss.
Patients should only use the medication prescribed specifically for them by their treating doctor.
Other Weight Loss Medication Costs
Other prescription options for weight management may include Mounjaro (tirzepatide) and Saxenda (liraglutide).
Private prices vary substantially between products, doses and pharmacies. Patients should therefore confirm current pricing with their pharmacy rather than relying on a fixed advertised monthly price.
The cheapest medication is not necessarily the most appropriate medication. Treatment selection should consider clinical suitability, effectiveness, contraindications, adverse effects, availability and affordability.
Factors Affecting the Total Cost of Weight Management Treatment
The medication itself may represent the largest expense, but patients should also consider:
- Medical consultation fees
- Follow-up consultations
- Pharmacy dispensing costs
- Pathology investigations where clinically indicated
- Dose changes during treatment
- Other medical monitoring required by the treating doctor
Long-term affordability should be considered before commencing treatment because weight management medication may require ongoing treatment.
How to Access Medical Weight Management Through AussieScripts
AussieScripts provides telehealth consultations with Australian-registered doctors for patients seeking assessment for medical weight management.
The process involves:
- Completing an online medical assessment.
- Review by an Australian-registered doctor.
- Assessment of medical history, BMI, current medications and clinical suitability.
- If clinically appropriate, a prescription may be issued.
- The patient can use their eScript at a pharmacy of their choice.
A prescription is not guaranteed. Treatment is prescribed only when the reviewing doctor considers it clinically appropriate.
Frequently Asked Questions
Is Wegovy subsidised by the PBS for weight loss in Australia?
No. Wegovy is not currently PBS-subsidised for weight loss. Patients prescribed Wegovy for weight management generally require a private prescription and pay the pharmacy's private price.
Is Wegovy approved in Australia?
Yes. Wegovy is registered by the TGA for chronic weight management in eligible adults. It also has additional TGA-approved indications.
If my BMI is over 35, can I get Wegovy for $25 through the PBS?
Not currently for weight loss. A high BMI alone does not provide access to PBS-subsidised Wegovy for weight management.
Is Ozempic subsidised for weight loss?
No. Ozempic's PBS listing applies to specified subsidised indications and eligibility requirements, not simply because a patient wishes to use semaglutide for weight loss.
Can I get Wegovy through telehealth?
A doctor can assess your suitability for prescription weight management medication through telehealth. If the doctor determines that treatment is clinically appropriate, an eScript may be issued.
How much does Wegovy cost privately?
Private prices vary between pharmacies and may also vary according to dose and formulation. Patients should check the current price with their pharmacy before commencing treatment.
Will Wegovy become PBS-subsidised in the future?
Government consideration of obesity medicines continues, but a recommendation, application or PBAC consideration should not be interpreted as an active PBS subsidy. Patients should check the current PBS Schedule for the latest status.
Start Your Weight Management Consultation
AussieScripts provides convenient access to Australian-registered doctors who can assess whether prescription weight management treatment is clinically appropriate for you.
Book a Weight Loss Consultation with AussieScripts today.
Information current as at September 2026. PBS listings, TGA indications, medicine availability and private pharmacy prices can change. Always check the current PBS Schedule and TGA information or discuss your treatment with your doctor or pharmacist.
Disclaimer
The information provided by AussieScripts is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. For advice tailored to your specific symptoms or health concerns, please consult one of our doctors or your regular GP.
